HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Arun K. Singh William C. Feng Stephen J. Sanofsky Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Singh, A. K. Articles by Sanofsky, S. J. Search for Related Content PubMed PubMed Citation Articles by Singh, A. K. Articles by Sanofsky, S. J.

Ann Thorac Surg 1992;54:538-540
© 1992 The Society of Thoracic Surgeons

---

Articles

Long-term results of St. Jude Medical valve in the tricuspid position

Division of Cardiothoracic Surgery, Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island USA

Accepted for publication February 14, 1992.

^_* Address reprint requests to Dr Singh, Suite 238, 110 Lockwood St, Providence, RI 02903.

Little is known of the St. Jude Medical heart valve's long-term clinical performance in the tricuspid position. Fourteen patients underwent tricuspid valve replacement between 1981 and 1984. Ages of the patients ranged from 32 to 81 years. Eight patients (68%) were in New York Heart Association class IV preoperatively. Twelve patients had other concomitant cardiac operations. One patient (8%) died within 30 days after operation, due to cerebrovascular accident. Postoperatively, all patients were anticoagulated with warfarin sodium and showed improvement in functional class. There were no mechanical valve failures or thromboses in patients on the anticoagulation regimen. Follow-up in all patients extended over 7 to 10 years with a mean of 8 years. There were six late deaths unrelated to valve function. The actuarial survival curve with these patients is 50% over 10 years. In conclusion, the St. Jude Medical valve is a good mechanical substitute in the tricuspid position, and we recommend its use when reconstruction is not possible and there is no contraindication for anticoagulation.

This article has been cited by other articles:

				J. E. Molina, C. L. Roberts, and D. G. Benditt Long-Term Follow-Up of Permanent Transvenous Pacing Systems Preserved During Tricuspid Valve Replacement Ann. Thorac. Surg., January 1, 2010; 89(1): 318 - 320. [Abstract] [Full Text] [PDF]

				R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1111 - 1128. [Full Text]

				B.-C. Chang, S.-H. Lim, G. Yi, Y. S. Hong, S. Lee, K.-J. Yoo, M. S. Kang, and B. K. Cho Long-Term Clinical Results of Tricuspid Valve Replacement Ann. Thorac. Surg., April 1, 2006; 81(4): 1317 - 1324. [Abstract] [Full Text] [PDF]

				Y. Sakamoto, K. Hashimoto, H. Okuyama, S. Ishii, T. Inoue, and K. Kinouchi Long-Term Results of Triple-Valve Procedure Asian Cardiovasc Thorac Ann, February 1, 2006; 14(1): 47 - 50. [Abstract] [Full Text] [PDF]

				N. A G Solomon, R. C H Lim, P. Nand, and K. J Graham Tricuspid Valve Replacement: Bioprosthetic or Mechanical Valve? Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 143 - 148. [Abstract] [Full Text] [PDF]

				A. Kalangos, J. Sierra, M. Beghetti, P. Trigo-Trindade, D. Vala, and J. Christenson Tricuspid valve replacement with a mitral homograft in children with rheumatic tricuspid valvulopathy J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1682 - 1687. [Abstract] [Full Text] [PDF]

				R. J. Shemin Tricuspid Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1001 - 1015. [Full Text]

				H. Kawano, T. Oda, S. Fukunaga, E. Tayama, T. Kawara, A. Oryoji, and S. Aoyagi Tricuspid valve replacement with the St. Jude Medical valve: 19 years of experience Eur J Cardiothorac Surg, November 1, 2000; 18(5): 565 - 569. [Abstract] [Full Text] [PDF]

				T. Sugimoto, M. Okada, N. Ozaki, T. Hatakeyama, and T. Kawahira LONG-TERM EVALUATION OF TREATMENT FOR FUNCTIONAL TRICUSPID REGURGITATION WITH REGURGITANT VOLUME: CHARACTERISTIC DIFFERENCES BASED ON PRIMARY CARDIAC LESION J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 463 - 471. [Abstract] [Full Text] [PDF]

				C. P. Ratnatunga, M.-B. Edwards, C. J. Dore, and K. M. Taylor Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses Ann. Thorac. Surg., December 1, 1998; 66(6): 1940 - 1947. [Abstract] [Full Text] [PDF]

				C. T. Bajzer, W. J. Stewart, D. M. Cosgrove, S. J. Azzam, K. L. Arheart, and A. L. Klein Tricuspid valve surgery and intraoperative echocardiography: Factors affecting survival, clinical outcome, and echocardiographic success J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1023 - 1031. [Abstract] [Full Text] [PDF]

				A. Ian Munro, W. R. Eric Jamieson, G. Frank, O. Tyers, and E. Germann Tricuspid valve replacement: Porcine bioprostheses and mechanical prostheses Ann. Thorac. Surg., August 1, 1995; 60(suppl_2): S470 - S474. [Abstract] [PDF]

				H. E. Scully and C. S. Armstrong Tricuspid valve replacement: Fifteen years of experience with mechanical prostheses and bioprostheses J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1035 - 1041. [Abstract] [Full Text]

				K. Nakano, H. Koyanagi, A. Hashimoto, G. Ohtsuka, and C. Nojiri Tricuspid valve replacement with the bileaflet St. Jude Medical valve prosthesis J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 888 - 892. [Abstract] [Full Text]

				A. J. Crumbley III and A. B. Van Bakel Tricuspid valve repair for biopsy-induced regurgitation after cardiac transplantation Ann. Thorac. Surg., October 1, 1994; 58(4): 1156 - 1160. [Abstract] [PDF]